U-87 MG

U-87 MG (Glioblastoma CDX Model) 

The U-87 MG line was derived from a glioblastoma of the brain. It represents one of the most aggressive brain cancers. U-87 MG has been extensively used in neuro-oncology drug development. Its reproducibility ensures value in translational glioblastoma research. 

Key Features: 

• Derived from human glioblastoma. 

• Highly proliferative brain tumor line. 

• Aggressive xenograft growth. 

• Represents advanced glioblastoma biology. 

Applications: 
U-87 MG supports therapeutic development in glioblastoma. Researchers apply it in biomarker validation and resistance mechanism studies. It is also used in testing drug delivery strategies for brain tumors. Its reproducibility ensures widespread use in neuro-oncology.